Trial intelligence / Profile preview

LR-PRP vs LP-PRP vs Corticosteroid in Knee Osteoarthritis

NCT05737173Phase 3Completed

Sponsor
Queen Savang Vadhana Memorial Hospital
Start
Aug 2020
Primary completion
Sep 2022
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of Leukocyte-Rich Platelet-Rich Plasma, Leukocyte-Poor Platelet Rich Plasma in osteoarthritis (OA), sponsored by Queen Savang Vadhana Memorial Hospital. Started Aug 2020; status: completed.

02

Drugs

Leukocyte-Rich Platelet-Rich PlasmaLeukocyte-Poor Platelet Rich Plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT05737173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05737173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call